This is not the most recent version of the article. View current version (29 JAN 2015)

Intervention Protocol

You have free access to this content

Retinoic acid post consolidation therapy for high-risk neuroblastoma

  1. Frank Peinemann1,*,
  2. Carmen Bartel2,
  3. Ulrich Grouven3,
  4. Frank Berthold4

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 31 JUL 2013

DOI: 10.1002/14651858.CD010685


How to Cite

Peinemann F, Bartel C, Grouven U, Berthold F. Retinoic acid post consolidation therapy for high-risk neuroblastoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD010685. DOI: 10.1002/14651858.CD010685.

Author Information

  1. 1

    Children's Hospital, University of Cologne, Cologne, NW, Germany

  2. 2

    Cologne, Germany

  3. 3

    Hannover Medical School, Hannover, Germany

  4. 4

    Children's Hospital, University of Cologne, Pediatric Oncology and Hematology, Cologne, Germany

*Frank Peinemann, Children's Hospital, University of Cologne, Kerpener Str. 62, Cologne, NW, 50937, Germany. pubmedprjournal@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 31 JUL 2013

SEARCH

This is not the most recent version of the article. View current version (29 JAN 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary aim of this study is to evaluate whether patients with high-risk neuroblastoma have an additional benefit in terms of overall survival if retinoic acid is added to the post consolidation therapy and whether retinoic acid has dose-limiting treatment-related severe adverse events.